#Israel #Tel Aviv #financial results #Annual Report #Israel Corp

Financial Results Announcement for Israel Corporation Ltd. (ILCO)

On March 25, 2026, Israel Corporation Ltd. (TASE: ILCO) revealed its financial figures for the fourth quarter and the annual period concluding on December 31, 2025. This latest disclosure sheds light on the company's performance amidst a dynamic business environment.

Key Financial Highlights for Q4 and Annual of 2025

The financial report encompasses several noteworthy metrics:

• - ILCO's Share in ICL Profit: The company reported a loss of $32 million in Q4 2025, a decline from a profit of $31 million in Q4 2024. The overall profit for 2025 amounted to $99 million, down from $179 million recorded in the previous year.

• - Net Profit from Prodalim: ILCO's share in the net profit from Prodalim registered at a loss of $1 million for Q4 2025, although it showed a nominal profit of $2 million for the entire year, contrasting with no earnings reported in 2024.

• - Amortization Costs: During this period, the amortization of excess costs related to held companies increased slightly, totaling $2 million for Q4 and $8 million for the annual figure.

• - Financing and General Administration: The operational results at the headquarters level reflected a loss of $3 million for Q4 and stabilized at zero for the total annual results.

• - Tax Income (Expense): The company benefited from a tax income of $3 million, compared to an expense of $1 million noted in Q4 2024, with total tax benefits for the year amounting to $15 million.

• - Net Profit to Shareholders: The net loss attributable to the shareholders for Q4 reached $37 million, a significant drop from the $31 million profit recorded in the same period of the previous year. The annual net profit for 2025 was reported at $87 million, down from $190 million.

Liquidity Status at the Headquarters

As of the close of the fiscal year on December 31, 2025, ILCO's liquidity position showed total financial liabilities standing at $679 million against investments in liquid assets of $721 million. Notably, the net cash position amounted to $73 million, reflecting an increase from $45 million reported as of September 30, 2025. This net cash includes the positive impact of derivative transactions which diminished the financial liabilities by $31 million.

Total Assets Overview

The comprehensive asset assessment as of December 31, 2025, revealed the following figures:

• - ICL Shares: Approximately 567 million shares at a market value of $3,253 million.
• - Prodalim Investments: Cost recorded at $118 million, with market valuation adjustments reflecting the current investments.
• - AKVA Group Shares: 6.6 million shares valued at $58 million.
• - Other Assets: Totaling $18 million.
• - Cumulative Total Assets: $3,520 million after accounting for net cash.

Recent Developments

ILCO's strategic movements throughout the fiscal year included:

• - Investment in Prodalim: On March 5, 2025, ILCO completed a significant investment agreement contributing $118 million to Prodalim.
• - Prodalim’s IPO: Following its IPO on February 24, 2026, which raised around NIS 370 million, ILCO's shareholding in Prodalim diluted from 27.5% to approximately 23.26% on a fully diluted basis.
• - Dividend Announcement: The board of directors sanctioned a dividend distribution of around $13 million on March 25, 2026, adhering to the company’s dividend policy, with payment scheduled for April 27, 2026.
• - Language Shift in Reporting: In line with a strategic decision, ILCO will transition to providing reports solely in English, starting from this release.

Conclusion

With these results, Israel Corporation Ltd. highlights the key aspects of its financial performance for 2025. The figures demonstrate the company's ability to navigate challenges while focusing on strategic investments and maintaining liquidity for future growth. For further details about ILCO, visit its official website or refer to their public filings on the Tel Aviv Stock Exchange.